Chimerix (CMRX) Competitors

Chimerix (NASDAQ:CMRX) and Zai Lab (NASDAQ:ZLAB) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their valuation, risk, earnings, dividends, institutional ownership, media sentiment, profitability, community ranking and analyst recommendations.

Which has more volatility and risk, CMRX or ZLAB?

Chimerix has a beta of -0.17, indicating that its share price is 117% less volatile than the S&P 500. Comparatively, Zai Lab has a beta of 1.09, indicating that its share price is 9% more volatile than the S&P 500.

Which has better valuation and earnings, CMRX or ZLAB?

Chimerix has higher earnings, but lower revenue than Zai Lab. Zai Lab is trading at a lower price-to-earnings ratio than Chimerix, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Chimerix	$212K	3,776.50	-$82.10M	-$0.99	-8.62
Zai Lab	$398.99M	8.52	-$334.62M	-$2.59	-11.98

Do analysts prefer CMRX or ZLAB?

Chimerix currently has a consensus target price of $8.53, indicating a potential downside of 0.02%. Zai Lab has a consensus target price of $47.37, indicating a potential upside of 52.70%. Given Zai Lab's stronger consensus rating and higher probable upside, analysts clearly believe Zai Lab is more favorable than Chimerix.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Chimerix	0 Sell rating(s)	3 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Zai Lab	0 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.75

Does the media favor CMRX or ZLAB?

In the previous week, Zai Lab had 10 more articles in the media than Chimerix. MarketBeat recorded 15 mentions for Zai Lab and 5 mentions for Chimerix. Chimerix's average media sentiment score of 0.93 beat Zai Lab's score of 0.81 indicating that Chimerix is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Chimerix	1 Very Positive mention(s)	2 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Zai Lab	12 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Does the MarketBeat Community believe in CMRX or ZLAB?

Chimerix received 165 more outperform votes than Zai Lab when rated by MarketBeat users. However, 64.53% of users gave Zai Lab an outperform vote while only 63.16% of users gave Chimerix an outperform vote.

Company	Underperform	Outperform
Chimerix	Outperform Votes 396 63.16%	Underperform Votes 231 36.84%
Zai Lab	Outperform Votes 231 64.53%	Underperform Votes 127 35.47%

Do insiders & institutionals believe in CMRX or ZLAB?

45.4% of Chimerix shares are held by institutional investors. Comparatively, 41.7% of Zai Lab shares are held by institutional investors. 13.1% of Chimerix shares are held by insiders. Comparatively, 13.9% of Zai Lab shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Is CMRX or ZLAB more profitable?

Chimerix has a net margin of 0.00% compared to Zai Lab's net margin of -76.14%. Zai Lab's return on equity of -36.97% beat Chimerix's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Chimerix	N/A	-50.78%	-44.94%
Zai Lab	-76.14%	-36.97%	-27.10%

Summary

Zai Lab beats Chimerix on 10 of the 18 factors compared between the two stocks.